Prostate + urinary health · Imaging + PSA + bloods + urine + clinical review
A coordinated prostate and urinary-health assessment combining prostate, kidney and urinary tract ultrasound, PSA blood testing, urine analysis and culture, a comprehensive blood profile, a 30-minute GP appointment and Pharmacist medication review.
A coordinated prostate pathway
The package combines structural ultrasound with PSA testing, urine testing, a broader blood profile and results-based clinical review. These components answer different questions and are intended to be interpreted together.
The first visit completes the investigations. Once the reports are available, the GP and Pharmacist review the results alongside symptoms, age, family history, medication and other risk factors.
Six core components
The package specification below follows the current LondonSono Prostate Health Check source content, adapted for PrivateSono.
Non-invasive transabdominal ultrasound of the prostate, kidneys and bladder.
Prostate-specific antigen testing interpreted with age, symptoms, urine results and imaging.
Urine testing for infection, blood, protein and other abnormalities relevant to urinary symptoms.
Approximately 25 markers across seven broader health categories, in addition to PSA.
Face-to-face review after imaging and laboratory results are available.
Medication review focused on prostate/urinary symptoms, kidney function and treatment safety.
PSA testing
PSA is a blood marker that can support assessment of prostate conditions and prostate-cancer risk, but it needs clinical context.
The NHS advises avoiding ejaculation, anal sex, vigorous exercise and cycling for 48 hours before a PSA test because these can raise PSA. If you have a urinary infection, PSA testing may need to be delayed after the infection has cleared.
There is currently no national NHS population-screening programme using PSA alone. Men considering PSA testing should understand the potential benefits, false-positive results, false-negative results and the possibility of further investigations.
~25-marker profile
The wider profile is designed to provide metabolic, renal, liver, thyroid, inflammatory and cardiovascular context during the GP review.
Prostate + kidney + urinary tract ultrasound
The source package uses a transabdominal urinary-tract examination rather than a prostate-only scan.
Transabdominal ultrasound is useful for prostate size and urinary-tract assessment but cannot reliably exclude clinically significant prostate cancer. Persistent concern, raised PSA or other risk factors may require specialist assessment and multiparametric MRI; biopsy provides tissue diagnosis when indicated.
Two-visit workflow
The source package deliberately separates investigation from results-based review.
Prostate/kidney/urinary ultrasound, PSA, comprehensive blood profile and urine analysis/culture are completed in one approximately 45–60 minute visit.
The source pathway states that the detailed written ultrasound report is typically available within 24 hours.
PSA, blood profile and urine culture are processed before the clinical review.
The source workflow schedules the review for the first Friday after Visit 1, followed by an integrated written report.
Seven optional add-ons
These source-page add-ons are charged separately and may be selected or recommended according to the results and clinical question.
Additional PSA refinement that may be useful for selected borderline or clinically uncertain PSA results.
Specialist urology review for raised PSA, significant lower urinary tract symptoms, recurrent infection or other prostate/urinary concerns.
Non-invasive assessment of urinary flow rate, voided volume and voiding pattern.
Multiparametric MRI pathway for men who need more detailed prostate assessment after PSA and clinical risk review.
Referral pathway for tissue diagnosis when biopsy is clinically indicated after specialist and imaging assessment.
Male hormone assessment for fatigue, low libido, erectile dysfunction or wider men’s health review.
Optional nutritional blood markers for fatigue, deficiency risk and wider health assessment.
Package value
The current source-page component pricing totals £669 when purchased separately.
Who may consider the package?
The decision to have PSA testing should be informed by age, symptoms, family history, ethnicity, personal preference and discussion of the test’s limitations.
Passing urine frequently or waking repeatedly at night can occur with benign prostate enlargement or other urinary conditions.
Difficulty starting, reduced flow or straining may indicate bladder-outlet obstruction or lower urinary tract dysfunction.
A sensation that the bladder is not empty may justify post-void residual assessment and broader urinary review.
A close family history of prostate cancer can increase risk and may influence the decision about PSA testing and further assessment.
Black men have a higher risk of prostate cancer and may wish to discuss PSA testing and individual risk assessment earlier.
Visible or persistent microscopic haematuria needs appropriate clinical evaluation and should not be assumed to arise from benign prostate enlargement.
Repeated UTIs can be associated with residual urine, obstruction, stones or other urinary abnormalities.
Men considering PSA testing without symptoms should understand the potential benefits and harms before deciding whether testing is right for them.
Acute inability to pass urine, severe pain with fever or sepsis symptoms, heavy visible haematuria with clots, or rapidly worsening illness should not wait for a routine screening appointment.
Results-based clinical interpretation
The source pathway includes a 30-minute GP appointment and Pharmacist medication review after the investigation reports are available, so the final plan is based on completed findings rather than one test in isolation.
Book online
Use the dedicated PrivateSono booking page to select the package, clinic and available appointment time.
The secure PrivateSono booking page opens in a new tab.
Clinic locations
Choose the available clinic through the PrivateSono booking page.
Central London
London, W1G 8EN — Marylebone / Harley Street medical district.
Book Central London →St Albans
St Albans, Hertfordshire, AL1 3HZ.
Book St Albans →Frequently asked questions
Common questions about PSA, ultrasound, preparation, blood testing and the two-visit workflow.
Call 020 7101 3377The package includes six components: prostate, kidney and urinary tract ultrasound; PSA blood test; urine analysis and culture; approximately 25-marker comprehensive blood profile; 30-minute GP appointment; and Pharmacist medication review.
The current source package is £599 all-inclusive. The same source lists the six components at £669 when purchased separately, a £70 package saving.
No. PSA is a risk-assessment blood marker, not a cancer diagnosis. It can be raised for non-cancerous reasons including benign prostate enlargement, prostatitis and urinary infection.
No. A normal PSA does not completely exclude prostate cancer. Symptoms, risk factors and clinical context still matter.
Transabdominal ultrasound can assess prostate size and gross structure but cannot reliably exclude clinically significant prostate cancer. If concern remains, specialist assessment and multiparametric MRI may be recommended, with biopsy where indicated.
The source package covers the prostate, both kidneys, urinary bladder and ureters where visible, with post-void residual measurement where appropriate.
A comfortably full bladder is needed for transabdominal prostate and bladder assessment. Follow the exact fluid instructions in your booking confirmation.
NHS guidance advises avoiding ejaculation, anal sex, vigorous exercise and cycling for 48 hours beforehand. A urinary infection can affect PSA, so testing may need to be delayed after the infection clears.
The source package includes FBC and ESR, kidney and liver function, bone/mineral markers, glucose and iron studies, TSH and Free T4, and a lipid profile. PSA is tested separately as the prostate-specific marker.
Urine analysis and culture can identify infection and help distinguish urinary or prostatitis-related causes that may influence symptoms and PSA interpretation.
Visit 1 completes the investigations. Visit 2 takes place after the results are available so the GP and Pharmacist can interpret the full set of findings together.
The current source pathway states that the detailed ultrasound report is typically available within 24 hours of Visit 1.
The source package lists Free PSA/PSA Density +£90, Urologist +£350, Uroflowmetry +£200, Prostate MRI referral +£500, Prostate biopsy referral +£1,000, Testosterone/SHBG +£200, and Vitamin D + B12 + Folate +£180.
The GP interprets PSA in context. Depending on the level, symptoms and risk factors, next steps may include repeat PSA, urology referral, multiparametric MRI and further investigation. A raised PSA does not automatically mean cancer.
No. The source package is designed for direct private booking without a GP referral.
Private prostate & urinary health assessment
Six coordinated components, ~25 blood markers plus PSA, and results-based GP and Pharmacist review.
